13F-HR filed by Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-14, with 95 holding rows worth $807,766,692.
- Accession
- 0001999371-24-006067
- Filer
- CIK 1773195
- Filed
- 2024-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 95 entries on the cover page, a total value of $807,766,692 stated on the cover page (in dollars after the unit check, H1), rows summing to $807,766,692 with VALUE read as dollars as filed, 13F file number 028-20754. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 700,000 | $66,423,000 | dollars as filed | put |
| MODERNA INC | 60770K107 | COM | 400,000 | $42,624,000 | dollars as filed | put |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 592,093 | $39,344,580 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 837,387 | $36,049,510 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 115,000 | $30,709,600 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,655,000 | $23,352,050 | dollars as filed | call |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 470,000 | $22,000,700 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 3,375,000 | $21,532,500 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 510,000 | $21,404,700 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 300,000 | $20,865,000 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 470,000 | $20,266,400 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 2,642,519 | $20,241,696 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,400,000 | $19,754,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 17,000,000 | $18,298,257 | dollars as filed | principal |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 730,492 | $15,581,394 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 410,000 | $15,551,300 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 817,833 | $13,158,933 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 82,143 | $12,846,344 | dollars as filed | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 300,000 | $12,681,000 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 810,253 | $11,910,719 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 845,606 | $11,901,904 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 150,000 | $11,263,500 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 139,758 | $11,152,688 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 165,000 | $9,698,700 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC | 02043QAB3 | NOTE 1.000% 9/1 | 10,000,000 | $9,448,755 | dollars as filed | principal |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 830,546 | $9,385,170 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 285,000 | $9,208,350 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 1,029,500 | $8,966,945 | dollars as filed | call |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 1,027,868 | $8,551,862 | dollars as filed | |
| INARI MED INC | 45332Y109 | COM | 175,000 | $8,396,500 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 164,589 | $8,377,580 | dollars as filed | |
| GERON CORP | 374163103 | COM | 2,500,000 | $8,250,000 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 225,000 | $7,920,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 250,000 | $7,730,000 | dollars as filed | call |
| OMEROS CORP | 682143AG7 | NOTE 5.250% 2/1 | 10,500,000 | $7,632,450 | dollars as filed | principal |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 286,200 | $6,768,630 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 1,268,825 | $6,509,072 | dollars as filed | |
| GRITSTONE BIO INC | 39868T105 | COM | 2,390,600 | $6,143,842 | dollars as filed | put |
| PERSPECTIVE THERAPEUTICS INC | 46489V104 | COM | 5,100,000 | $6,069,000 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 40,000 | $5,978,000 | dollars as filed | call |
| ABSCI CORPORATION | 00091E109 | COM | 1,025,000 | $5,822,000 | dollars as filed | |
| COHERUS BIOSCIENCES INC | 19249HAB9 | BOND | 9,000,000 | $5,784,786 | dollars as filed | principal |
| SAVARA INC | 805111101 | COM | 1,150,000 | $5,727,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 80,000 | $5,608,800 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 80,000 | $5,464,800 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 500,000 | $5,270,000 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 550,339 | $5,195,200 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 577,100 | $5,182,358 | dollars as filed | put |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 250,000 | $5,157,500 | dollars as filed | call |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 100,000 | $4,922,000 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 26,746 | $4,758,916 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 144,400 | $4,665,564 | dollars as filed | call |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 1,000,000 | $4,480,000 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 65,000 | $4,430,400 | dollars as filed | call |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 258,588 | $4,406,340 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 327,959 | $4,233,951 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 50,000 | $4,100,000 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 1,600,000 | $4,080,000 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 160,000 | $4,019,200 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 75,000 | $3,767,250 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 350,000 | $3,678,500 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 50,000 | $3,460,000 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 120,000 | $3,432,000 | dollars as filed | |
| IMMUNITYBIO INC | 45256X103 | COM | 589,400 | $3,165,078 | dollars as filed | put |
| NEXTCURE INC | 65343E108 | COM | 1,359,037 | $3,030,653 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 450,000 | $2,952,000 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 100,000 | $2,893,000 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 275,000 | $2,596,000 | dollars as filed | call |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 250,000 | $2,587,500 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 50,000 | $2,545,000 | dollars as filed | call |
| REGENXBIO INC | 75901B107 | COM | 110,000 | $2,317,700 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 202,599 | $2,236,693 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 75,000 | $2,030,250 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 75,000 | $1,894,500 | dollars as filed | call |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 286,585 | $1,768,229 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 25,000 | $1,712,250 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 1,761,778 | $1,588,419 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 50,000 | $1,546,000 | dollars as filed | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 133,500 | $1,504,545 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 150,274 | $1,193,176 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 450,009 | $1,156,523 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 50,000 | $1,145,000 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 125,000 | $963,750 | dollars as filed | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 700,000 | $896,000 | dollars as filed | |
| ANNOVIS BIO INC | 03615A108 | COM | 72,900 | $867,510 | dollars as filed | put |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 60,000 | $538,800 | dollars as filed | call |
| PROMIS NEUROSCIENCES INC | 74346M406 | COM NEW | 265,958 | $507,980 | dollars as filed | |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 187,204 | $486,730 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 27,777 | $473,320 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 328,817 | $453,767 | dollars as filed | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 142,300 | $426,900 | dollars as filed | put |
| PASSAGE BIO INC | 702712100 | COM | 264,266 | $356,759 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 10,000 | $217,500 | dollars as filed | |
| CASSAVA SCIENCES INC | 14817C115 | WARR | 24,200 | $97,524 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 75,000 | $22,440 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001999371-24-006067 | this filing | 2024-05-14 | acceptance time not in the bulk data set |